These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27116214)

  • 21. Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration.
    Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Kawasaki R; Sekiryu T; Okada AA; Iida T
    Am J Ophthalmol; 2015 Apr; 159(4):627-33. PubMed ID: 25555799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of choroidal vascular hyperpermeability on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.
    Cho HJ; Kim HS; Jang YS; Han JI; Lew YJ; Lee TG; Kim CG; Kim JW
    Am J Ophthalmol; 2013 Dec; 156(6):1192-1200.e1. PubMed ID: 24011522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters.
    Chang YS; Kim JH; Kim JW; Lee TG; Kim CG
    Korean J Ophthalmol; 2016 Aug; 30(4):272-9. PubMed ID: 27478354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy.
    Cheng CK; Peng CH; Chang CK; Hu CC; Chen LJ
    Retina; 2011 May; 31(5):846-56. PubMed ID: 21317837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHOROIDAL VASCULAR HYPERPERMEABILITY AS A PREDICTOR OF TREATMENT RESPONSE FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Yanagi Y; Ting DSW; Ng WY; Lee SY; Mathur R; Chan CM; Yeo I; Wong TY; Cheung GCM
    Retina; 2018 Aug; 38(8):1509-1517. PubMed ID: 28704255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
    Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
    Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polypoidal choroidal vasculopathy and treatments.
    Gomi F; Tano Y
    Curr Opin Ophthalmol; 2008 May; 19(3):208-12. PubMed ID: 18408495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy.
    Morimoto M; Matsumoto H; Mimura K; Akiyama H
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1891-1897. PubMed ID: 28669041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
    Lee JY; Chung H; Kim HC
    Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Muakkassa NW; Chin AT; de Carlo T; Klein KA; Baumal CR; Witkin AJ; Duker JS; Waheed NK
    Retina; 2015 Nov; 35(11):2252-9. PubMed ID: 26457400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jirarattanasopa P; Ooto S; Nakata I; Tsujikawa A; Yamashiro K; Oishi A; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3663-72. PubMed ID: 22570352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presenting characteristics and prevalence of polypoidal choroidal vasculopathy in Scandinavian patients with treatment-naïve exudative age-related macular degeneration.
    Lorentzen TD; Subhi Y; Sørensen TL
    Acta Ophthalmol; 2018 Aug; 96(5):475-480. PubMed ID: 29193780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathy.
    Pai SA; Shetty R
    Acta Ophthalmol; 2009 Nov; 87(7):806-7. PubMed ID: 18721250
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of clinical features and 3-month treatment response among three different choroidal thickness groups in polypoidal choroidal vasculopathy.
    Kong M; Kim SM; Ham DI
    PLoS One; 2017; 12(9):e0184058. PubMed ID: 28886052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
    Palkovits S; Seidel G; Pertl L; Malle EM; Hausberger S; Makk J; Singer C; Osterholt J; Herzog SA; Haas A; Weger M
    Retina; 2017 Dec; 37(12):2262-2268. PubMed ID: 28129216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.
    Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Nishida K
    Br J Ophthalmol; 2012 Mar; 96(3):394-9. PubMed ID: 21719568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration.
    Shin JY; Kwon KY; Byeon SH
    Acta Ophthalmol; 2015 Sep; 93(6):524-32. PubMed ID: 25581639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Ricci F; Calabrese A; Regine F; Missiroli F; Ciardella AP
    Retina; 2012 Jul; 32(7):1280-8. PubMed ID: 22218148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.
    Cho M; Barbazetto IA; Freund KB
    Am J Ophthalmol; 2009 Jul; 148(1):70-8.e1. PubMed ID: 19403115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphological Difference of Choroidal Vasculature Between Polypoidal Choroidal Vasculopathy and Neovascular AMD on OCT: From the Perspective of Pachychoroid.
    Lai K; Zhou L; Zhong X; Huang C; Gong Y; Xu F; Ma L; Chen G; Cheng L; Lu L; Jin C
    Ophthalmic Surg Lasers Imaging Retina; 2018 Oct; 49(10):e114-e121. PubMed ID: 30395671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.